Viewing Study NCT06149559


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2026-01-28 @ 5:18 PM
Study NCT ID: NCT06149559
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2023-09-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
Sponsor: UCB Biopharma SRL
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module